Meeting
2017 ASCO Annual Meeting
Translating prostate cancer working group (PCWG) criteria into a quantitative progression biomarker in metastatic castration resistant prostate cancer (mCRPC).
Authors
Aseem Anand
Memorial Sloan Kettering Cancer Center, New York, NY
Aseem Anand , Glenn Heller , Howard I. Scher , Michael J. Morris
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 35, 2017 (suppl; abstr 5068)
DOI
10.1200/JCO.2017.35.15_suppl.5068
Abstract #
5068
Poster Bd #
142
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Translating Prostate Cancer Working Group 2 (PCWG2) progression criteria into a quantitative response biomarker in metastatic castration-resistant prostate cancer (mCRPC).
First Author: Aseem Anand
Poster
2017 Genitourinary Cancers Symposium
Association of PET index quantifying skeletal uptake in NaF PET/CT images with overall survival in prostate cancer patients.
First Author: Sarah Lindgren Belal
Poster
2024 ASCO Genitourinary Cancers Symposium
Nucleosome profiling at AR binding sites (ARBS) to provide a prognostic tool for metastatic castration-resistant prostate cancer (mCRPC).
First Author: Chao Dai
Poster
2024 ASCO Genitourinary Cancers Symposium
Lipidomic profiling as a biomarker for prostate cancer diagnosis and response to enzalutamide (Enza).
First Author: Sara Bleve